Ординатура / Офтальмология / Английские материалы / Pediatric Ophthalmology for Primary Care 3rd edition_Wright, Farzavandi_2008
.pdf
98 |
Pediatric Ophthalmology for Primary Care |
Inner retinal layer
Outer retinal layer
“Cartwheel” macular change
Figure 7 8.
X-linked retinoschisis. The splitting occurs at the nerve fiber layer.
the inferior temporal quadrant. Schisis can be difficult to see if the retinal separation is shallow. Late in the disease, secondary retinal pigment epithe lial changes can occur, and pigment can sometimes take on the appearance of retinitis pigmentosa. Vision often remains in the range of 20/70; however, vitreous hemorrhages can occur in areas of schisis, and the retina can detach in some patients, resulting in very poor vision.
Congenital Stationary Night Blindness
Congenital stationary night blindness is a hereditary, nonprogressive disor der of night vision. It can be inherited as autosomal dominant, autosomal recessive, or X linked. The autosomal recessive pattern is rare and usually associated with consanguineous relationships or found in Jewish families. Visual acuity may be normal, although many cases have poor vision. Poor vision can be secondary to myopia, as patients with congenital night blind ness are highly myopic. The night blindness usually occurs during the first
Acquired Visual Loss in Childhood |
99 |
decade of life as an isolated complaint. Color vision, visual field, and fundus examinations are normal. There are 2 distinct variants, however, that have fundus findings. These are Oguchi disease and fundus albipunctatus, both autosomal recessive. They are stable, nonprogressive disorders and have no known treatment.
Cone Dystrophy
Cone dystrophy is a rare retinal dystrophy that preferentially affects cones more than rods. It is typically an autosomal dominant disorder; however, autosomal recessive and X linked varieties have been described. This cone dystrophy usually presents during the first 3 decades of life, caus ing decreased central visual acuity. Other symptoms include photophobia (hypersensitivity to light), dark to light adaptation difficulty, and a history of better vision at night versus during the day. Color vision is significantly affected early in the development of the disorder. Visual fields demonstrate a central scotoma. Cone dystrophy, in most cases, is isolated to the retina
without systemic involvement; however, renal retinal dysplasia, which pref erentially involves cone photoreceptors, has been described. The course of the disease is progressive and can be quite variable even among members of the same family. Vision often declines to the 20/200 level by the end of the third decade. For those experiencing photophobia, tinted lenses may help reduce the symptoms.
Retinitis Pigmentosa
Retinitis pigmentosa is an overall description for a large group of inher ited disorders that affect the retinal pigment epithelium (outer pigmented layer of the retina). The retinal pigment epithelium is critical to the health of the neurosensory retina, as the retinal pigment epithelium nourishes and revitalizes the outer segments of the rods and cones. Diseases of the outer segments of the rods and cones and the retinal pigment epithelium result in decreased function of the rods and cones and ultimately, over time, can cause blindness. These inherited diseases may be confined to the eye; however, many are associated with systemic abnormalities. Retinitis pig mentosa is a major health problem, as approximately 1 in 4,000 individuals are affected. The inheritance pattern is 20% autosomal dominant, 20% auto somal recessive, 10% X linked recessive, and 50% sporadic. The autosomal
100 |
Pediatric Ophthalmology for Primary Care |
recessive and X linked recessive forms tend to develop early in childhood or adolescent years and have a rapid, progressive course. Autosomal dominant cases tend to occur later in adulthood and have a slower, milder course.
The cause of progressive, retinal pigmentary epithelial atrophy has undergone intensive study. Recent molecular biological breakthroughs have shown the primary defect in many types of retinitis pigmentosa is a point mutation in the rhodopsin gene. Rhodopsin is a critical protein in the outer segments of the rods. Over time, the abnormal protein builds up and results in rod death and secondary retinal pigment epithelial atrophy. Retinitis pig mentosa is mostly a rod disease and first affects the peripheral retina where the rod concentration is very high. Some types of retinitis pigmentosa affect both rods and cones, while other inherited retinal diseases preferentially affect cones.
Symptoms associated with retinitis pigmentosa include poor night vision with abnormal dark adaptation. Rods are responsible for our night vision (scotopic vision), and loss of rods first affects our ability to adapt to dark conditions. Patients also experience peripheral visual field loss and develop tunnel vision. Late in the disease, the tunnel vision can be so severe that it greatly restricts patient activity. Central visual acuity loss can occur late in the disease.
Ophthalmoscopic findings are peripheral bone spicule hyperpigmenta tion (Figure 7 9). This is an area of clumped pigmentation with adjacent areas of hypopigmentation and retinal pigment epithelial atrophy. The optic nerve will take on a waxy pallor and the retinal vessels will be significantly attenuated. Electrophysiologic testing is important to document decreased electroretinogram from poor dark adaptation.
Systemic Diseases Associated With Retinitis Pigmentosa (Table 7 1)
Usher Syndrome
Usher syndrome is an autosomal recessive form of retinitis pigmentosa (Figure 7 9) associated with sensorineural deafness. In some cases, the deafness is associated with abnormal vestibular function. The combination of visual and auditory deprivation has devastating social implications, and affected individuals often have severe psychologic problems.
Acquired Visual Loss in Childhood |
101 |
Figure 7 9.
Usher syndrome. Fundus photograph showing typical retinitis pigmentosa findings of bone spicule hyperpigmentary changes, attenuated retinal vessels, and optic disc pallor (atrophy).
Refsum Syndrome
Refsum syndrome is an autosomal recessive defect in fatty acid metabolism that results in increased phytanic acid throughout the body. This metabolic defect results in peripheral neuropathy, cerebellar ataxia, deafness, and reti nitis pigmentosa. The time of onset is usually in the third decade. The diag nosis is confirmed by the presence of elevated levels of phytanic acid in the serum. Restricting dietary phytanic acid early in life may slow the progres sion of the disease.
Bassen Kornzweig Syndrome (Abetalipoproteinemia)
Bassen Kornzweig syndrome is a rare autosomal recessive disorder caused by malabsorption of intestinal fat. Patients have decreased serum levels of cholesterol, triglycerides, and fat soluble vitamins A, E, and K. Diagnosis is confirmed by very low serum cholesterol. Patients present with steatorrhea, acanthocytosis (a thorny or spiny erythrocyte characterized by multiple spiny cytoplasmic projections), ataxia, and childhood onset retinitis pigmen tosa. Dietary supplementation with vitamin E can be helpful.
102 |
Pediatric Ophthalmology for Primary Care |
Table 7.1. Neurologic Disorders Accompanying Retinitis Pigmentosa
Errors in Lipid Metabolism 3-Hydroxydicarboxylic aciduria Abetalipoproteinemia
Refsum disease
Neuronal ceroid lipofuscinosis Infantile form
Late infantile form Juvenile form
Errors in Mucopolysaccharide Metabolism Hurler disease (MPS IH)
Hunter disease (MPS II) Scheie disease (MPS IS)
Peroxisomal Disorders Zellweger disease
Neonatal adrenoleukodystrophy Infantile Refsum disease
Mitochondrial Disorders Kearns-Sayre syndrome
Heredodegenerative Disease Friedreich ataxia Cerebellar ataxia, dominant Familial spastic paraplegia Hallervorden-Spatz disease Cockayne syndromes Chédiak-Higashi syndrome Hallgren syndrome
Other Hereditary Disorders
Gyrate atrophy due to ornithine aminotransferase deficiency Sjögren-Larsson syndrome
Laurence-Moon syndrome Alström syndrome
Usher syndrome
Laurence Moon Bardet Biedl Syndrome
Laurence Moon Bardet Biedl syndrome is a disorder consisting of obe sity, mental retardation, hypogenitalism, and retinitis pigmentosa. This syndrome has been divided into 2 forms: the Laurence Moon syndrome, which is associated with spinocerebellar ataxia, hypogonadism, and spastic paraplegia, and the Bardet Biedl syndrome, which includes polydactyly. Bardet Biedl syndrome is autosomal recessive. These patients may have subtle findings and the diagnosis may be overlooked. Examination of feet
Acquired Visual Loss in Childhood |
103 |
and hands may require radiography to determine polydactyly or brachydac tyly. Recently, the genotype of Bardet Biedl syndrome has been mapped to chromosome 16.
Renal Retinal Syndromes
Retinitis pigmentosa is associated with certain renal diseases including
Senior Loken syndrome and Maldino Mainzer syndrome. These are usu ally autosomal recessively inherited and feature retinal pigment epithelial degeneration. Senior Loken syndrome consists of juvenile renal failure, often leading to transplantation and progressive retinitis pigmentosa.
Neurodegenerative Disorders Associated With
Vision Loss (Tables 7 2 and 7 3)
Neurodegenerative disease can cause visual loss through retinal degenera tion, optic neuropathy, or cortical blindness.
Neuronal Ceroid Lipofuscinosis
Batten Disease
Neuronal ceroid lipofuscinosis (NCL) refers to a group of lysosomal storage disorders of lipopigments with secondary neuronal degeneration. Neonates are not blind at birth, but start losing milestones between 6 months and 3 years of age. These are autosomal recessive generalized disorders with pro gressive psychomotor delay, seizures, and choreoathetosis. Patients develop a retinal degeneration that leads to blindness and an attenuated or extin guished electroretinogram. Intracellular inclusions can be seen by electron microscopy in neurons, pericytes, macrophages, smooth muscle cells, lipo cytes, and capillary endothelial cells. Diagnosis is made by biopsy of the skin and rectum. Conjunctival biopsy may also be helpful.
Haltia Santavuori Disease
Haltia Santavuori disease is an infantile form of NCL characterized by nor mal development until 6 months of age. Then progressive regression with loss of psychomotor milestones, onset of seizures, pigmentary retinal degen eration, and optic atrophy occur. Patients are usually blind by 2 to 3 years of age, and death occurs around 6 to 7 years of age.
Table 7.2 Neurodegenerative Conditions With Onset in Late Infancy or Early Childhood
|
|
Principal Ophthalmic |
|
|
Defective Organelle |
Condition |
Manifestation |
Principal Systemic Manifestations |
Biochemical Defect |
|
|
|
|
|
Lysosome |
Metachromatic leuko- |
Optic atrophy, nystagmus |
Weakness, ataxia, dementia |
Arylsulfatase A |
sphingolipidoses |
dystrophy |
|
|
|
|
Gaucher disease type 3 |
Abducens palsy, ocular |
Dysphagia, spasticity, dementia, |
Glucocerebrosidase |
|
|
motor apraxia |
myoclonus organomegaly, |
|
|
|
|
osseous lesions |
|
|
Niemann-Pick type IS |
Pigmentary maculopathy |
Organomegaly, mental retardation |
Sphingomyelinase |
|
(formerly type B) |
|
|
|
|
Niemann-Pick type IIS |
Vertical gaze palsy |
Organomegaly, psychomotor |
Unknown |
|
(formerly type C) |
|
retardation |
|
|
|
|
|
|
Lysosome |
Aspartylglycosaminuria |
Crystalline cataracts |
Coarse facies, mental retardation, |
Aspartylglycosaminidase |
oligosaccharidoses |
|
|
diarrhea, recurrent infections |
|
|
Fucosidosis |
Tortuous conjunctival |
Coarse facies, psychomotor dete- |
α-L-fucosidase |
|
|
vessels |
rioration, dysostosis multiplex, |
|
|
|
|
angiokeratoma |
|
|
Mannosidosis type II |
Spoke-like cataracts, cor- |
Coarse facies, psychomotor dete- |
α-mannosidase |
|
|
neal opacities |
rioration, dysostosis multiplex, |
|
|
|
|
deafness, recurrent infections |
|
|
Schindler neuroaxonal |
Optic atrophy, nystagmus |
Weakness, peripheral neuropathy, |
α-N-acetylgalactosami |
|
dystrophy |
|
psychomotor retardation |
nidase |
|
|
|
|
|
104
Care Primary for Ophthalmology Pediatric
Table 7.2 Neurodegenerative Conditions With Onset in Late Infancy or Early Childhood, continued
|
|
Principal Ophthalmic |
|
|
Defective Organelle |
Condition |
Manifestation |
Principal Systemic Manifestations |
Biochemical Defect |
|
|
|
|
|
Lysosome mucolipidosis |
Mucolipidosis III |
Corneal clouding, |
Dysostosis multiplex, mental |
UPD-N-acetylglucos- |
|
(Pseudo-Hurler |
pigmentary reti- |
retardation, coarse facies (mild) |
amine: lysosomal |
|
polydystrophy) |
nopathy, hyperopic |
|
enzyme |
|
|
astigmatism |
|
N-acetylglucosami- |
|
|
|
|
nyl-l-phosphotrans- |
|
|
|
|
ferase |
|
|
|
|
|
Lysosome mucopoly- |
MPS 1H (Hurler) |
Corneal clouding, pigmen- |
Dysostosis multiplex, organomegaly, |
α-L-iduronidase |
saccharidoses |
|
tary retinopathy |
coarse facies, mental retardation |
|
|
MPS II (Hunter) |
Pigmentary retinopathy, |
Dysostosis multiplex, organomegaly, |
Iduronate sulfatase |
|
|
corneal clouding (rare) |
coarse facies, psychomotor |
|
|
|
|
retardation |
|
|
MPS III (Sanfilippo) |
Pigmentary retinopathy |
Severe mental retardation, mild |
Heparan N-sulfatase |
|
|
|
dysostosis multiplex, deafness |
(MPS IIIA) |
|
|
|
|
α-L-acetylglucosaminida |
|
|
|
|
se (MPS IIIB) |
|
|
|
|
Acetyl-CoA: |
|
|
|
|
α-glucosaminidase |
|
|
|
|
acetyltransferase |
|
|
|
|
(MPS IIIC) |
|
|
|
|
N-acetylglucosamine |
|
|
|
|
6-sulfatase (MPS IIID) |
|
|
|
|
|
Lysosome ceroidoses |
Late infantile NCL |
Pigmentary retinopathy, |
Seizures, ataxia, spasticity, loss |
Unknown |
|
(Jansky-Bielschowsky) |
optic atrophy |
of speech |
|
|
|
|
|
|
Childhood in Loss Visual Acquired
105
Table 7.2 Neurodegenerative Conditions With Onset in Late Infancy or Early Childhood, continued
|
|
Principal Ophthalmic |
|
|
Defective Organelle |
Condition |
Manifestation |
Principal Systemic Manifestations |
Biochemical Defect |
|
|
|
|
|
Mitochondria |
MELAS syndrome |
Hemianopsia, cortical |
Seizures, lactic acidosis, hemiparesis |
Mitochondrial tRNA |
|
|
visual loss |
|
|
|
|
|
|
|
Peroxisome |
Adrenoleukodystrophy |
Cortical blindness, optic |
Quadriparesis, dysarthria, cognitive |
Lignoceroyl CoA ligase |
|
|
atrophy |
decline, Addison disease |
|
|
|
|
|
|
Unknown |
Riley-Day syndrome (fa- |
Dry eyes, corneal hypoes- |
Vomiting, motor delay, poor |
Unknown |
|
milial dysautonomia) |
thesia, band keratopa- |
temperature control, postural |
|
|
|
thy, optic atrophy |
hypotension, emotional lability |
|
|
Chédiak-Higashi |
Iris transillumination, foveal |
Oculocutaneous albinism, |
Unknown |
|
syndrome |
hypoplasia, nystagmus |
recurrent infections, ataxia, |
|
|
|
|
polyneuropathy |
|
|
Neuroaxonal dystrophy |
Optic atrophy, cortical |
Weakness, peripheral neuropathy, |
Unknown |
|
|
blindness, nystagmus, |
spasticity |
|
|
|
esotropia |
|
|
|
Ataxia telangiectasia |
Conjunctival telangiectasia, |
Ataxia, polyneuropathy, immuno- |
Unknown |
|
(Louis-Bar syn- |
dysmetric saccades, |
logic impairment |
|
|
drome) |
nystagmus, optic |
|
|
|
|
atrophy |
|
|
|
|
|
|
|
106
Care Primary for Ophthalmology Pediatric
Table 7-3. Neurodegenerative Conditions With Onset in Late Childhood or Adolescence |
|
|
||||
|
|
Principal Ophthalmic |
Principal Systemic |
|
|
|
Defective Organelle |
Condition |
Manifestation |
Manifestations |
Biochemical Defect |
|
|
|
|
|
|
|
|
|
Lysosome |
Metachromatic leukodys- |
Optic atrophy |
Personality changes, ataxia, incon- |
Arylsulfatase A |
|
|
sphingolipidoses |
trophy (late onset |
|
tinence, gallstones |
|
|
|
|
|
|
|
|
|
|
Lysosome |
Sialidosis (type I) |
Cherry red spots, nyctalopia, |
Myoclonus, ataxia |
Neuroaminidase (oligo- |
|
|
oligosaccharidoses |
|
cataracts |
|
saccharide sialidase) |
|
Acquired |
|
|
|
|
|
|
|
Lysosome ceroidosis |
Juvenile NCL |
Pigmentary maculopathy |
Behavioral problems, cognitive |
Unknown |
|
|
|
|
|||||
|
(Spielmeyer-Vogt) |
|
decline, seizures, spasticity |
|
|
Visual |
|
|
|
|
|
|
|
Peroxisome |
Refsum’s disease |
Pigmentary retinopathy, |
Ataxia, hearing loss, cardiac |
Phytanic acid |
|
in Loss |
(presumed) |
|
nyctalopia, cataracts |
arrhythmia |
α-hydroxylase |
|
|
|
|
|
|
|
|
Childhood |
Mitochondria |
Chronic progressive exter- |
Ptosis, ophthalmoplegia, |
Weakness, heart block, ataxia, hear- |
Unknown |
|
|
Fukuhara disease (MERRF) |
Optic atrophy |
Myoclonus, ataxia, weakness |
Mitochondrial tRNAlys |
|
|
|
|
nal ophthalmoplegia |
pigmentary retinopathy, |
ing loss, endocrine problems |
|
|
|
|
(CPEO)/Kearns-Sayre |
nystagmus |
|
|
|
|
|
|
|
|
|
|
|
None |
SSPE |
Macular chorioretinitis, optic |
Cognitive decline, myoclonus, |
Immune response to |
|
|
|
|
atrophy, papilledema |
epilepsy, rigidity |
measles virus |
|
|
|
|
|
|
|
|
107 |
